Sysmex Sysmex Inostics Sees Ultra-Sensitive Leukemia Liquid Biopsy as Potential CDx Premium Sysmex also recently formed a companion diagnostic development partnership with Qiagen, which could help with its efforts in this area. Qiagen, Sysmex Form Global Companion Diagnostic Development Pact The companies will develop and commercialize liquid biopsy CDx assays using Sysmex's Plasma-Safe-SeqS next-generation sequencing technology. Sysmex Obtains Japan Marketing Approval for Use of Saliva With Coronavirus Kit To enable the use of saliva in addition to other types of samples, Sysmex requested a change to a marketing approval it obtained in March. Sysmex Partec to Distribute De Novo Flow Cytometry Software Worldwide By running FCS Express on the CyFlow Cube V2m device, Sysmex Parec believes customers will benefit from an analysis software that allows advanced reporting capabilities and data export options. Sysmex Obtains Japan Marketing Approval to Distribute BGI Genomics Coronavirus Kit Sysmex anticipates delivering the kit to Japanese medical institutions this month for diagnosis of the SARS-CoV-2 infection. Feb 11, 2020 Oxford Gene Technology Expands NGS Offering Into Constitutional Cytogenetics Premium Jan 22, 2020 Sysmex Wins Chinese Approval for Breast Cancer IVD Reagent Nov 26, 2019 Biolidics, Sysmex Partner on Cancer Liquid Biopsy Development Nov 1, 2019 Sysmex, Optim to Establish Digital Medicine Joint Venture Aug 2, 2019 Comparison of KRAS Liquid Biopsy Kits Confirms Differences at Low Mutant Allele Fraction Aug 2, 2019 Sysmex Gets Japanese Manufacturing, Marketing Approval for Colorectal Cancer Screening Assay Nov 28, 2018 Sysmex, MolecularMD to Collaborate for CDx Development, Commercialization Sep 28, 2018 New Products Posted to GenomeWeb: Roche, Sysmex Inostics, Mawi DNA Technologies, More Nov 14, 2017 Genedrive, Sysmex Sign Asia Pacific Distribution Agreement for HCV Test Oct 16, 2017 Genedrive, Sysmex Europe Sign EMEA Distribution Agreement for HCV Test, MDx Platform Jul 27, 2017 BioMérieux, Sysmex Dissolve Japanese Joint Venture May 31, 2017 Sysmex to Acquire Oxford Gene Technology May 20, 2016 In Brief This Week: Qiagen; DiaSorin; Quest; Agilent; Thermo Fisher Scientific; and More Apr 15, 2016 Expansion of Liquid Biopsy Test Sites Planned by Merck KGaA, Sysmex Premium Apr 7, 2016 Merck KGaA, Sysmex Inostics Garner CE Mark for Liquid Biopsy CRC Test Mar 28, 2016 Sysmex, Clearbridge BioMedics to Partner on CTC Liquid Biopsy System Feb 29, 2016 Sysmex Inks Global Deal with Streck Feb 16, 2016 Eisai, Sysmex to Develop Dx, CDx for Dementia Jun 1, 2015 Sysmex, LabCorp Collaborate on Blood Testing for Personalized Medicine Apr 22, 2015 Sysmex Inostics Inks OncoBEAM Distribution Deal with IndivuTest Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.